The EPO evaluates patent applications based on several criteria, including novelty, inventive step, and industrial applicability. For cancer-related patents, the EPO examines whether the invention is new, non-obvious, and useful in a practical sense. This rigorous evaluation process ensures that only truly innovative and applicable inventions receive patent protection.
